Get the Stockscreener App
6.40
4.58%
0.28
Immucell Corp stock is traded at $6.40, with a volume of 6,952.
It is up +4.58% in the last 24 hours and down -1.39% over the past month.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
See More
Previous Close:
$6.12
Open:
$6.29
24h Volume:
6,952
Relative Volume:
0.31
Market Cap:
$57.89M
Revenue:
$23.84M
Net Income/Loss:
$-3.81M
P/E Ratio:
-12.80
EPS:
-0.5
Net Cash Flow:
$-713.00K
1W Performance:
+5.04%
1M Performance:
-1.39%
6M Performance:
+19.63%
1Y Performance:
+67.98%
1-Day Range:
$6.14
$6.42
1-Week Range:
$5.96
$6.42
52-Week Range:
$3.34
$7.60
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.40 | 55.36M | 23.84M | -3.81M | -713.00K | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Immucell Corp Stock (ICCC) Latest News
Trend analysis for ImmuCell Corporation this week2025 Major Catalysts & Long Hold Capital Preservation Plans - Newser
Published on: 2025-08-31 15:07:40 - Newser
ImmuCell Corporation stock daily chart insightsJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
Tick level data insight on ImmuCell Corporation volatility2025 Top Gainers & Verified Short-Term Trading Plans - Newser
How to recover losses in ImmuCell Corporation stockJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - Newser
What earnings revisions data tells us about ImmuCell CorporationQuarterly Market Summary & AI Forecast for Swing Trade Picks - Newser
What momentum shifts mean for ImmuCell CorporationTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Using portfolio simulators with ImmuCell Corporation includedQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
ImmuCell Corporation stock trend outlook and recovery pathJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser
Published on: 2025-08-30 22:15:50 - Newser
Is ImmuCell Corporation trending in predictive chart modelsWeekly Risk Report & Entry Point Confirmation Signals - Newser
Sentiment analysis tools applied to ImmuCell CorporationWeekly Stock Summary & Accurate Buy Signal Alerts - Newser
Published on: 2025-08-30 16:41:36 - Newser
Volatility clustering patterns for ImmuCell CorporationJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Will a bounce in ImmuCell Corporation offer an exitPortfolio Value Report & Long Hold Capital Preservation Tips - Newser
Will breakout in ImmuCell Corporation lead to full recoveryWeekly Trade Review & Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-31 03:36:35 - Newser
Risk vs reward if holding onto ImmuCell CorporationMarket Sentiment Review & Entry Point Confirmation Signals - Newser
Risk adjusted return profile for ImmuCell Corporation analyzedEarnings Trend Report & Real-Time Buy Signal Alerts - Newser
Real time scanner hits for ImmuCell Corporation explainedTreasury Yields & Fast Gaining Stock Reports - Newser
What the charts say about ImmuCell Corporation today2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Will ImmuCell Corporation stock go up soonWeekly Trend Recap & Real-Time Volume Spike Alerts - Newser
ImmuCell Corporation Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - thegnnews.com
ImmuCell Corporation stock volume spike explainedAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Published on: 2025-08-29 12:56:32 - Newser
How to use a screener to detect ImmuCell Corporation breakoutsMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
What moving averages say about ImmuCell CorporationEarnings Risk Report & High Return Stock Watch Alerts - Newser
Historical volatility pattern of ImmuCell Corporation visualizedPortfolio Return Report & Smart Allocation Stock Tips - Newser
Applying big data sentiment scoring on ImmuCell CorporationInsider Buying & Comprehensive Market Scan Insights - Newser
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):